PULSE BIOSCIENCES, INC. — Director's Dealing 2017

Sep 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-09-14

Reporting Person: Zanganeh Maky (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-14	Common Stock	P	13000	$12.2263	Acquired	315725	Direct
2017-09-14	Common Stock	P	9000	$13.5486	Acquired	324725	Direct
2017-09-18	Common Stock	P	7775	$15.0213	Acquired	332500	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	90474	Indirect

Footnotes

F1: This is the weighted average purchase price of the shares, which ranged from $11.8658 to $12.5499 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F2: This is the weighted average purchase price of the shares, which ranged from $12.9397 to $13.88 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F3: This is the weighted average purchase price of the shares, which ranged from $14.68 to $15.52 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.